Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CVS Health Corporation (CVS) stocks in Canada

Learn how to easily invest in CVS Health Corporation stocks.

CVS Health Corporation is a healthcare plans business based in the US. CVS Health Corporation stocks (CVS.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $89.99 – an increase of 2.41% over the previous week. CVS Health Corporation employs 213,000 staff and has a trailing 12-month revenue of around $284 billion.

How to buy shares in CVS Health Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CVS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

CVS Health Corporation stock price (NYSE:CVS)

Use our graph to track the performance of CVS stocks over time.

CVS Health Corporation shares at a glance

Information last updated 2022-01-23.
Latest market close$104.86
52-week range$66.43 - $106.69
50-day moving average $98.51
200-day moving average $87.62
Wall St. target price$113.41
PE ratio 17.7274
Dividend yield $2 (2.17%)
Earnings per share (TTM) $5.73

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy CVS Health Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

CVS Health Corporation price performance over time

Historical closes compared with the close of $104.86 from 2022-01-26

1 week (2022-01-21) 3.25%
1 month (2021-12-24) N/A
3 months (2021-10-27) 19.04%
6 months (2021-07-28) 25.88%
1 year (2021-01-28) 44.42%
2 years (2020-01-28) 46.00%
3 years (2019-01-28) 60.73%
5 years (2017-01-27) 34.87%

Is CVS Health Corporation under- or over-valued?

Valuing CVS Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CVS Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CVS Health Corporation's P/E ratio

CVS Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, CVS Health Corporation shares trade at around 18x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

CVS Health Corporation's PEG ratio

CVS Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0889. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CVS Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

CVS Health Corporation's EBITDA

CVS Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $17.8 billion.

The EBITDA is a measure of a CVS Health Corporation's overall financial performance and is widely used to measure a its profitability.

CVS Health Corporation financials

Revenue TTM $284 billion
Operating margin TTM 4.68%
Gross profit TTM $48.2 billion
Return on assets TTM 3.55%
Return on equity TTM 10.56%
Profit margin 2.67%
Book value $56.25
Market capitalisation $134.1 billion

TTM: trailing 12 months

CVS Health Corporation's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CVS Health Corporation.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

CVS Health Corporation's total ESG risk score

Total ESG risk: 18.73

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CVS Health Corporation's overall score of 18.73 (as at 01/01/2019) is excellent – landing it in it in the 19th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like CVS Health Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

CVS Health Corporation's environmental score

Environmental score: 1.92/100

CVS Health Corporation's social score

Social score: 9.06/100

CVS Health Corporation's governance score

Governance score: 2.75/100

CVS Health Corporation's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. CVS Health Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that CVS Health Corporation hasn't always managed to keep its nose clean.

CVS Health Corporation share dividends

27%

Dividend payout ratio: 26.52% of net profits

Recently CVS Health Corporation has paid out, on average, around 26.52% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.17% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CVS Health Corporation shareholders could enjoy a 2.17% return on their shares, in the form of dividend payments. In CVS Health Corporation's case, that would currently equate to about $2 per share.

While CVS Health Corporation's payout ratio might seem fairly standard, it's worth remembering that CVS Health Corporation may be investing much of the rest of its net profits in future growth.

CVS Health Corporation's most recent dividend payout was on 1 February 2022. The latest dividend was paid out to all shareholders who bought their shares by 20 January 2022 (the "ex-dividend date").

Have CVS Health Corporation's shares ever split?

CVS Health Corporation's shares were split on a 2:1 basis on 7 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CVS Health Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CVS Health Corporation shares which in turn could have impacted CVS Health Corporation's share price.

CVS Health Corporation share price volatility

Over the last 12 months, CVS Health Corporation's shares have ranged in value from as little as $66.4267 up to $106.6897. A popular way to gauge a stock's volatility is its "beta".

CVS.US volatility(beta: 0.84)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CVS Health Corporation's is 0.8414. This would suggest that CVS Health Corporation's shares are less volatile than average (for this exchange).

CVS Health Corporation overview

CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2020, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site